Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 1 / Research Article
A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases Table 1 The three centralities of 21 compounds were all higher than the average in C-T-D network.
MOL ID Molecule name Structure Degree centrality (DC) Betweenness centrality (BC) Closeness centrality (CC) MOL000675 Oleic acid 17 0.1394 0.4577 MOL002526 δ -Guaijene8 0.0242 0.304 MOL000911 Terpilene 8 0.0248 0.3916 MOL000126 (−)-Nopinene 6 0.0398 0.4362 MOL000069 Palmitic acid 6 0.0332 0.3779 MOL000118 (L)-Alpha-terpineol 5 0.0119 0.3892 MOL000254 Eugenol 5 0.0297 0.4305 MOL003521 Isohomogenol 5 0.0083 0.3869 MOL000677 (1R, 4R)-4-Isopropyl-1,6-dimethyltetralin 5 0.0067 0.3916 MOL002392 Deltoin 5 0.0093 0.3916 MOL002417 Fuzitine 5 0.0086 0.3801 MOL000431 Coumarin 5 0.0127 0.3757 MOL003525 Pyruvophenone 5 0.0253 0.3631 MOL000198 (R)-Linalool 4 0.0075 0.3736 MOL000131 Linoleic acid 4 0.0181 0.414 MOL001393 Myristic acid 4 0.0146 0.3693 MOL000932 Alpha-farnesene 4 0.0121 0.3652 MOL000991 Cinnamaldehyde 4 0.0121 0.3652 MOL002295 Cinnamic acid 3 0.0141 0.4037 MOL000249 Methylcinnamate 3 0.0141 0.4037 MOL003531 3-Methoxycinnamaldehyde 3 0.0141 0.4037